Sandra M Yoder
Overview
Explore the profile of Sandra M Yoder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
255
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rolsma S, Yoder S, Nargi R, Brady E, Jimenez-Truque N, Thomsen I, et al.
J Pediatric Infect Dis Soc
. 2023 Apr;
12(5):298-305.
PMID: 37029694
Background: Respiratory syncytial virus (RSV) is a major cause of respiratory disease in infants, making vaccination an attractive preventive strategy. Due to earlier reports of vaccine-enhanced disease in RSV-naive children,...
2.
Self W, Wheeler A, Stewart T, Schrager H, Mallada J, Thomas C, et al.
Chest
. 2022 Jul;
162(5):982-994.
PMID: 35780813
Background: Convalescent plasma has been one of the most common treatments for COVID-19, but most clinical trial data to date have not supported its efficacy. Research Question: Is rigorously selected...
3.
Pilkinton M, Nicholas K, Warren C, Smith R, Yoder S, Talbot H, et al.
Vaccine
. 2016 Dec;
35(2):329-336.
PMID: 27919633
Background: Influenza related morbidity and mortality disproportionately impacts older adults. The serologic response to vaccine is diminished in older adults; however, high dose inactivated influenza vaccine (HD IIV) has shown...
4.
Thornburg N, Zhang H, Bangaru S, Sapparapu G, Kose N, Lampley R, et al.
J Clin Invest
. 2016 Mar;
126(4):1482-94.
PMID: 26950424
Avian H7N9 influenza viruses are group 2 influenza A viruses that have been identified as the etiologic agent for a current major outbreak that began in China in 2013 and...
5.
Engelhardt B, Paczesny S, Jung D, Daguindau E, Jagasia M, Savani B, et al.
Haematologica
. 2016 Jan;
101(5):e204-8.
PMID: 26819055
No abstract available.
6.
Engelhardt B, Sengsayadeth S, Jagasia M, Savani B, Kassim A, Lu P, et al.
Exp Hematol
. 2012 Aug;
40(12):974-982.e1.
PMID: 22885125
Regulatory T cells (Tregs) are a subset of CD4(+) T cells that are characterized by the expression of CD25 and Foxp3 and are capable of suppressing alloimmune responses. We assessed...
7.
Engelhardt B, Jagasia S, Crowe Jr J, Griffith M, Savani B, Kassim A, et al.
Blood
. 2012 Jan;
119(10):2417-21.
PMID: 22262764
Chronic inflammation and decreased frequency of regulatory T cells (Tregs) in visceral adipose tissue contribute to the propagation of insulin resistance to diabetes mellitus. We tested the hypothesis that new-onset...
8.
Rock M, McKinney B, Yoder S, Prudom C, Wright D, Crowe Jr J
J Immunol Methods
. 2011 Aug;
374(1-2):13-7.
PMID: 21854782
Human respiratory syncytial virus (RSV) and human metapneumovirus (MPV) are two of the most common causes of serious viral lower respiratory tract illness in humans. CD8+ T cells have been...
9.
Sutherland J, Chang C, Yoder S, Rock M, Maynard J
Clin Vaccine Immunol
. 2011 Apr;
18(6):954-62.
PMID: 21508166
Despite more than 50 years of vaccination, disease caused by the bacterium Bordetella pertussis persists, with rates increasing in industrialized countries over the past decade. This rise may be attributed...
10.
Rock M, Yoder S, Talbot T, Edwards K, Crowe Jr J
J Infect Dis
. 2006 Jul;
194(4):435-43.
PMID: 16845626
Background: Recent primary vaccine trials of diluted Aventis Pasteur smallpox vaccine (APSV) demonstrated that immunization "take" rates, defined by the presence of a vesicle or pustule ("take") at the inoculation...